Loading resource…

UpToDate, Inc.
Cryptogenic organizing pneumonia (COP) is a diffuse interstitial lung disease resulting from injury to the alveolar wall. It is often associated with various conditions and can respond well to systemic glucocorticoid therapy. The document discusses treatment protocols, including the use of steroids and immunosuppressive agents, and outlines the management of patients with different severities of the disease. It also highlights the importance of updated evidence in guiding clinical practice.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

CHALLENGES OF SARCOIDOSIS AND ITS MANAGEMENT
Same clinical topic · Pulmonology

THE NEW ERA OF ADD-ON ASTHMA TREATMENTS: WHERE DO WE STAND?
Same clinical topic · Pulmonology

PLEURAL EFFUSION IN CRITICALLY ILL PATIENTS AND INTENSIVE CARE SETTING
Same clinical topic · Pulmonology

OBESITY AND ACUTE PULMONARY EMBOLISM
Same clinical topic · Pulmonology

Management of Life-Threatening Asthma
Same clinical topic · Pulmonology

Management of Life-Threatening Asthma
Same clinical topic · Pulmonology

INTERSTITIAL LUNG DISEASES
Same clinical topic · Pulmonology

DIAGNOSTIC ACCURACY OF CHEST X-RAY SCREENING FOR SILICOSIS: A SYSTEMATIC REVIEW, META-ANALYSIS AND MODELLING STUDY
Same clinical topic · Pulmonology

Definitions of non-response and response to biological therapy for severe asthma: a systematic review
Same clinical topic · Pulmonology